Your Health. Your Family. Your Choice.
Administered by: Private Purchased by: Private
Life Threatening? No
Write-up: This is in follow-up to report(s) previously submitted on 4/13/2007. Initial and follow up information has been received from a registered nurse, via a company representative, concerning the nurse''s daughter, a 22 year old female patient, who on 19-JAN-2007 was vaccinated with the first dose, 0.5ml, IM, of GARDASIL (Lot# 654540/0800F). There was no concomitant medication. On 19-JAN-2007, beginning at 2:00pm, the patient "experienced numbness and tenderness around the injection site." The nurse reported that her daughter had a painful deltoid for eight weeks and that sometimes the pain woke her daughter up at night and continued for a month, and indicated that "contact with the area was extremely painful. There was no swelling or erythema." On 19-FEB-2007 (previously reported as 18-FEB-2007), the patient had recovered from the numbness and tenderness, and the second dose of GARDASIL was then administered without any problems. The patient sought unspecified medical attention. No further information is expected.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166